Identi Healthcare Ltd (TLV:IDNT)
Israel · Delayed Price · Currency is ILS · Price in ILA 190.30
-4.60 (-2.36%)
Sep 23, 2026, 5:24 PM IDT
Identi Healthcare Revenue
Identi Healthcare had revenue of 7.48M ILS in the half year ending June 30, 2026, with 82.61% growth. This brings the company's revenue in the last twelve months to 12.44M, up 13.76% year-over-year. In the year 2025, Identi Healthcare had annual revenue of 9.90M, down -1.89%.
Revenue (ttm)
12.44M
Revenue Growth
+13.76%
P/S Ratio
2.31
Revenue / Employee
401.19K
Employees
31
Market Cap
28.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.90M | -191.00K | -1.89% |
| Dec 31, 2024 | 10.09M | 39.00K | 0.39% |
| Dec 31, 2023 | 10.05M | 594.00K | 6.28% |
| Dec 31, 2022 | 9.46M | 1.38M | 17.10% |
| Dec 31, 2021 | 8.08M | 978.00K | 13.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Evogene | 4.94M |
| BioLineRx | 4.15M |
| Nextage Therapeutics | 2.51M |
| Merchavia Holdings and Investments | 77.00K |